Tessa K.
- Country
- Belgium
- Department
- Hematology
Research Overview
- Phase III Multicenter Trial of Allogeneic CD4+ and CD8+ T Lymphocytes for Chemo-Refractory CMV, EBV, and AdV Infections Post-Allogeneic Stem Cell Transplantation
- Phase 3 Randomized Trial of Ciltacabtagene Autoleucel vs. Pomalidomide, Bortezomib, and Dexamethasone or Daratumumab, Pomalidomide, and Dexamethasone in Relapsed Lenalidomide-Refractory Multiple Myeloma
- Phase 2 Multicohort Open-Label Study of Ciltacabtagene Autoleucel CAR-T Therapy Targeting BCMA in Multiple Myeloma Patients
Data & Insights
Has run more than one trial at 33 of 92 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating various blood cancers, with particular focus on multiple myeloma and acute myeloid leukemia. Their research extends to innovative approaches for B-cell acute lymphoblastic leukemia treatment.
- Multiple Myeloma Management
- Leukemia Treatment Strategies
- Blood Cancer Therapeutics
Transplant Medicine
The investigator has extensive experience in allogeneic stem cell transplantation and its complications. Their work includes managing graft-versus-host disease and post-transplant viral infections.
- Stem Cell Transplantation
- GVHD Treatment
- Post-transplant Care
Immunotherapy
Their research encompasses advanced immunotherapeutic approaches, including dendritic cell vaccination and multispecific T-cell transfer. The investigator works with novel cellular therapies targeting various hematologic conditions.
- Cellular Therapy Development
- Cancer Immunotherapy
- Targeted Therapeutic Approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.